Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3G8YH
|
|||
| Drug Name |
HP-5000
|
|||
| Indication | Knee osteoarthritis [ICD-11: FA01; ICD-10: M15-M19, M47; ICD-9: 715] | Phase 3 | [1] | |
| Company |
Noven Pharmaceuticals Tokyo, Japan
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04683627) A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.